After 2 cycles of gemtuzumab ozogamicin, the patient achieved complete remission with clearance of leukemic and abnormal mast cells. A pediatric patient with refractory systemic mastocytosis (SM) ...

Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

A ready-made version of a cutting-edge cancer immunotherapy can effectively defeat blood cancers, a new study says.

HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless of treatment employed, according ...

After Hunter became too weak to walk to classes, she underwent a blood test. When doctors received the results, they urged ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.